226 related articles for article (PubMed ID: 32950105)
1. TV-circRGPD6 Nanoparticle Suppresses Breast Cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis.
Lin X; Chen W; Wei F; Xie X
Mol Ther; 2021 Jan; 29(1):244-262. PubMed ID: 32950105
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.
Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
Theranostics; 2017; 7(19):4805-4824. PubMed ID: 29187905
[No Abstract] [Full Text] [Related]
3. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract][Full Text] [Related]
4. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
5. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
[TBL] [Abstract][Full Text] [Related]
6. MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth.
Li M; Pan M; You C; Zhao F; Wu D; Guo M; Xu H; Shi F; Zheng D; Dou J
Breast Cancer Res; 2020 Mar; 22(1):26. PubMed ID: 32143670
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.
Pan M; Li M; You C; Zhao F; Guo M; Xu H; Li L; Wang L; Dou J
J Cell Physiol; 2020 Feb; 235(2):1405-1416. PubMed ID: 31347176
[TBL] [Abstract][Full Text] [Related]
8. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
9. Metformin mediates induction of miR-708 to inhibit self-renewal and chemoresistance of breast cancer stem cells through targeting CD47.
Tan W; Tang H; Jiang X; Ye F; Huang L; Shi D; Li L; Huang X; Li L; Xie X; Xie X
J Cell Mol Med; 2019 Sep; 23(9):5994-6004. PubMed ID: 31273952
[TBL] [Abstract][Full Text] [Related]
10. miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.
Hwang-Verslues WW; Chang PH; Wei PC; Yang CY; Huang CK; Kuo WH; Shew JY; Chang KJ; Lee EY; Lee WH
Oncogene; 2011 May; 30(21):2463-74. PubMed ID: 21258409
[TBL] [Abstract][Full Text] [Related]
11. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
Shimono Y; Zabala M; Cho RW; Lobo N; Dalerba P; Qian D; Diehn M; Liu H; Panula SP; Chiao E; Dirbas FM; Somlo G; Pera RA; Lao K; Clarke MF
Cell; 2009 Aug; 138(3):592-603. PubMed ID: 19665978
[TBL] [Abstract][Full Text] [Related]
13. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
14. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo.
Chen JH; Huang WC; Bamodu OA; Chang PM; Chao TY; Huang TH
BMC Cancer; 2019 Jun; 19(1):634. PubMed ID: 31248373
[TBL] [Abstract][Full Text] [Related]
15. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
[TBL] [Abstract][Full Text] [Related]
16. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.
Okuda H; Xing F; Pandey PR; Sharma S; Watabe M; Pai SK; Mo YY; Iiizumi-Gairani M; Hirota S; Liu Y; Wu K; Pochampally R; Watabe K
Cancer Res; 2013 Feb; 73(4):1434-44. PubMed ID: 23384942
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
[TBL] [Abstract][Full Text] [Related]
19. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_002178 Promotes the Growth and Migration of Breast Cancer Cells and Maintains Cancer Stem-like Cell Properties Through Regulating miR-1258/KDM7A Axis.
Li W; Yang X; Shi C; Zhou Z
Cell Transplant; 2020; 29():963689720960174. PubMed ID: 32951449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]